Aren van Waarde

6.8k total citations
212 papers, 5.0k citations indexed

About

Aren van Waarde is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Aren van Waarde has authored 212 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 59 papers in Cellular and Molecular Neuroscience and 47 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Aren van Waarde's work include Receptor Mechanisms and Signaling (50 papers), Neuroscience and Neuropharmacology Research (41 papers) and Pharmacological Receptor Mechanisms and Effects (32 papers). Aren van Waarde is often cited by papers focused on Receptor Mechanisms and Signaling (50 papers), Neuroscience and Neuropharmacology Research (41 papers) and Pharmacological Receptor Mechanisms and Effects (32 papers). Aren van Waarde collaborates with scholars based in Netherlands, Japan and Belgium. Aren van Waarde's co-authors include Philip H. Elsinga, Rudi Dierckx, Willem Vaalburg, Guido van den Thillart, Erik F. J. de Vries, Kiichi Ishiwata, Fanja Kesbeke, Anna A. Rybczynska, Nisha K. Ramakrishnan and Petra Doze and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Physiological Reviews.

In The Last Decade

Aren van Waarde

210 papers receiving 4.8k citations

Peers

Countries citing papers authored by Aren van Waarde

Since Specialization

Citations

This map shows the geographic impact of Aren van Waarde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aren van Waarde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aren van Waarde more than expected).

Fields of papers citing papers by Aren van Waarde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aren van Waarde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aren van Waarde. The network helps show where Aren van Waarde may publish in the future.

Co-authorship network of co-authors of Aren van Waarde

This figure shows the co-authorship network connecting the top 25 collaborators of Aren van Waarde. A scholar is included among the top collaborators of Aren van Waarde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aren van Waarde. Aren van Waarde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of the adenosine A2A receptor antagonist KW6002 on the dopaminergic system, motor performance, and neuroinflammation in a rat model of Parkinson's disease 2024 ·Neuropharmacology ·(unknown), Erik F. J. de Vries, (unknown), Rodrigo Moraga‐Amaro, (unknown), Lara Barazzuol, Rudi Dierckx, Aren van Waarde	6
2	Characterization of a novel model for atherosclerosis imaging: the apolipoprotein E-deficient rat 2023 ·EJNMMI Research ·Jürgen W. A. Sijbesma, Aren van Waarde, (unknown), (unknown), Uwe J.F. Tietge, Jan‐Luuk Hillebrands, Marian Bulthuis, Hendrik Buikema, (unknown), Marit Westerterp, Fan Liu, Hendrikus H. Boersma, Rudi Dierckx, Riemer H. J. A. Slart	3
3	Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Lara García-Varela, David Vállez García, Pablo Aguiar, Takeharu Kakiuchi, Hiroyuki Ohba, Norihiro Harada, Shingo Nishiyama, Tetsuro Tago, Philip H. Elsinga, Hideo Tsukada, Nicola Antonio Colabufo, Rudi Dierckx, Aren van Waarde, Jun Toyohara, Ronald Boellaard, Gert Luurtsema	10
4	Mapping Arginase Expression with ¹⁸F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids 2021 ·Journal of Nuclear Medicine ·Gonçalo S. Clemente, Inês F. Antunes, (unknown), (unknown), Jürgen W. A. Sijbesma, Aren van Waarde, Rogier C. Buijsman, Nicole Willemsen‐Seegers, Reinoud Gosens, Herman Meurs, Alexander Dömlingꝉ, Philip H. Elsinga	4
5	Synthesis and Evaluation of ¹⁸F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-¹⁸F-Fluoro-5α-Dihydrotestosterone 2021 ·Journal of Nuclear Medicine ·Inês F. Antunes, (unknown), (unknown), Aren van Waarde, Rudi Dierckx, Douwe F. Samplonius, Wijnand Helfrich, Philip H. Elsinga, Erik F. J. de Vries, Igle J. de Jong	8
6	Evaluation of a Novel P-glycoprotein Inducer Using [18F]MC225 and PET 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Lara García-Varela, David Vállez García, Manuel Rodríguez-Pérez, Rodrigo Moraga‐Amaro, Nicola Antonio Colabufo, Pablo Aguiar, Tomás Sobrino, Rudi Dierckx, Aren van Waarde, Philip H. Elsinga, Gert Luurtsema	1
7	Pharmacokinetic Modeling of (R)-[¹¹C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates 2020 ·Molecular Pharmaceutics ·Lara García-Varela, David Vállez García, Takeharu Kakiuchi, (unknown), Shingo Nishiyama, Tetsuro Tago, Philip H. Elsinga, Hideo Tsukada, Nicola Antonio Colabufo, Rudi Dierckx, Aren van Waarde, Jun Toyohara, Ronald Boellaard, Gert Luurtsema	5
8	Monitoring the Crosstalk Between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 with PET 2020 ·Molecular Imaging and Biology ·Inês F. Antunes, Geke A.P. Hospers, Jürgen W. A. Sijbesma, Ate S. Boerema, Aren van Waarde, Andor W.J.M. Glaudemans, Rudi Dierckx, Elisabeth G.E. de Vries, Erik F. J. de Vries	3
9	性ステロイドホルモンと脳機能研究のためのツールとしてのPETイメージング【Powered by NICT】 2018 ·Journal of Neuroendocrinology ·Rodrigo Moraga‐Amaro, Aren van Waarde, Janine Doorduin, Erik F. J. de Vries	1
10	Test-Retest Stability of Cerebral 2-Deoxy-2-[18F]Fluoro-D-Glucose ([18F]FDG) Positron Emission Tomography (PET) in Male and Female Rats 2018 ·Molecular Imaging and Biology ·Jürgen W. A. Sijbesma, Aren van Waarde, David Vállez García, Hendrikus H. Boersma, Riemer H. J. A. Slart, Rudi Dierckx, Janine Doorduin	8
11	Cutamesine Overcomes REM Sleep Deprivation-Induced Memory Loss: Relationship to Sigma-1 Receptor Occupancy 2014 ·Molecular Imaging and Biology ·Nisha K. Ramakrishnan, (unknown), Gert Luurtsema, Csaba Nyakas, Philip H. Elsinga, Kiichi Ishiwata, Rudi Dierckx, Aren van Waarde	8
12	Potential applications for sigma receptor ligands in cancer diagnosis and therapy 2014 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Aren van Waarde, Anna A. Rybczynska, Nisha K. Ramakrishnan, Kiichi Ishiwata, Philip H. Elsinga, Rudi Dierckx	132
13	Serotonin-2C antagonism augments the effect of citalopram on serotonin and dopamine levels in the ventral tegmental area and nucleus accumbens 2014 ·Neurochemistry International ·(unknown), (unknown), Martijn van Faassen, Eliyahu Dremencov, Gunnar Flik, Ido P. Kema, Johan A. den Boer, Aren van Waarde, Rudi Dierckx, Fokko J. Bosker	8
14	A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [18F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging 2014 ·Bioorganic & Medicinal Chemistry ·(unknown), Riccardo Castelli, Adriaan W. Tuin, Herman S. Overkleeft, Rosalina Wisastra, Frank J. Dekker, (unknown), Rainer Bischoff, Aren van Waarde, Rudi Dierckx, Philip H. Elsinga	14
15	Probes for Non-invasive Matrix Metalloproteinase-targeted Imaging with PET and SPECT 2013 ·Current Pharmaceutical Design ·(unknown), Aren van Waarde, Rainer Bischoff, Ruth Oltenfreiter, Christophe Van de Wiele, Rudi Dierckx, Philip H. Elsinga	55
16	MicroPET scans of rodents with spontaneous pituitary tumors, using the sigma ligand C-11-SA4503 2011 ·Data Archiving and Networked Services (DANS) ·Nisha K. Ramakrishnan, Anna A. Rybczynska, Csaba Nyakas, (unknown), Jürgen W. A. Sijbesma, (unknown), Kiichi Ishiwata, Rudi Dierckx, Aren van Waarde	1
17	Positron Emission Tomography Studies on Binding of Central Nervous System Drugs and P-Glycoprotein Function in the Rodent Brain 2004 ·Molecular Imaging and Biology ·Philip H. Elsinga, N. Harry Hendrikse, Joost Bart, Aren van Waarde, Willem Vaalburg	39
18	Quantification of β-adrenoceptor density in the human heart with (S)-[11C]CGP 12388 and a tracer kinetic model 2002 ·European Journal of Nuclear Medicine and Molecular Imaging ·Petra Doze, Philip H. Elsinga, Aren van Waarde, Remge M. Pieterman, Jan Pruim, Willem Vaalburg, Antoon T. M. Willemsen	22
19	Myocardial and pulmonary uptake of S-1′-[18F]fluorocarazolol in intact rats reflects radioligand binding to β-adrenoceptors 1995 ·European Journal of Pharmacology ·Aren van Waarde, Philip H. Elsinga, Otto-Erich Brodde, Gerben M. Visser, Willem Vaalburg	21
20	Teleosts in hypoxia: Aspects of anaerobic metabolism 1985 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Guido van den Thillart, Aren van Waarde	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact